Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01162798 · ClinicalTrials.gov registry record · NA

Preterm Infant Growth

A NA study, sponsored by Société des Produits Nestlé (SPN).

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT01162798: Completed NA study, sponsored by Société des Produits Nestlé (SPN).

NCT01162798 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01162798, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

The purpose of this study is to assess growth of preterm infants fed a test formula compared to a standard formula up to the first 4 months of corrected gestational age.

Primary Outcome

weight gain assessed monthly

Interventions

  • OTHER infant formula
  • OTHER control infant formula

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2010-09
Est. Completion 2014-09
Phase NA

What the finished NCT01162798 record still lists

NCT01162798 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 2 interventions - of which infant formula is the first listed.

NCT01162798 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01162798 about?

NCT01162798 is a clinical study titled "Preterm Infant Growth". The purpose of this study is to assess growth of preterm infants fed a test formula compared to a standard formula up to the first 4 months of corrected gestational age.

What is the current status of trial NCT01162798?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2010-09. Estimated completion is 2014-09.

What interventions are being tested in trial NCT01162798?

The interventions under investigation include: infant formula (OTHER), control infant formula (OTHER).

Who is sponsoring clinical trial NCT01162798?

This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01162798's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01162798, the US trial registry maintained by the National Library of Medicine. NCT01162798 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.